Company AIT Therapeutics Inc Nasdaq
Equities
US0014481099
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Beyond Air
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 21-08-31 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Andrew Colin
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Jeff Myers
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-26 |
Michael Gaul
COO | Chief Operating Officer | 70 | 20-04-30 |
Edward Barger
IRC | Investor Relations Contact | - | 22-09-30 |
Kori-Ann Taylor
SAM | Sales & Marketing | - | 21-05-19 |
Peter Senior
PRN | Corporate Officer/Principal | - | 21-05-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 15-07-31 |
William Forbes
BRD | Director/Board Member | 62 | 18-08-12 |
Erick Lucera
BRD | Director/Board Member | 57 | 17-08-09 |
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Robert Carey
BRD | Director/Board Member | 65 | 19-02-12 |
Yoori Lee
BRD | Director/Board Member | 51 | 18-01-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,900,821 | 37,322,801 ( 81.31 %) | 0 | 81.31 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |